These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 32835666)

  • 21. Linking ACE2 and angiotensin II to pulmonary immunovascular dysregulation in SARS-CoV-2 infection.
    Seltzer S
    Int J Infect Dis; 2020 Dec; 101():42-45. PubMed ID: 32950735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systematic profiling of ACE2 expression in diverse physiological and pathological conditions for COVID-19/SARS-CoV-2.
    Li Y; Xu Q; Ma L; Wu D; Gao J; Chen G; Li H
    J Cell Mol Med; 2020 Aug; 24(16):9478-9482. PubMed ID: 32639084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypothesis: Sex-Related Differences in ACE2 Activity May Contribute to Higher Mortality in Men Versus Women With COVID-19.
    Salah HM; Mehta JL
    J Cardiovasc Pharmacol Ther; 2021 Mar; 26(2):114-118. PubMed ID: 33078623
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interaction of COVID-19 With Common Cardiovascular Disorders.
    Boulos PK; Freeman SV; Henry TD; Mahmud E; Messenger JC
    Circ Res; 2023 May; 132(10):1259-1271. PubMed ID: 37167359
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiotensin-converting enzyme 2 and COVID-19 in cardiorenal diseases.
    Sharma RK; Li J; Krishnan S; Richards EM; Raizada MK; Mohandas R
    Clin Sci (Lond); 2021 Jan; 135(1):1-17. PubMed ID: 33399851
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sex, Hormones, Immune Functions, and Susceptibility to Coronavirus Disease 2019 (COVID-19)-Related Morbidity.
    Gotluru C; Roach A; Cherry SH; Runowicz CD
    Obstet Gynecol; 2021 Mar; 137(3):423-429. PubMed ID: 33543899
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coronavirus and Cardiovascular Disease, Myocardial Injury, and Arrhythmia: JACC Focus Seminar.
    Giustino G; Pinney SP; Lala A; Reddy VY; Johnston-Cox HA; Mechanick JI; Halperin JL; Fuster V
    J Am Coll Cardiol; 2020 Oct; 76(17):2011-2023. PubMed ID: 33092737
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SARS-CoV-2 and the possible connection to ERs, ACE2, and RAGE: Focus on susceptibility factors.
    Stilhano RS; Costa AJ; Nishino MS; Shams S; Bartolomeo CS; Breithaupt-Faloppa AC; Silva EA; Ramirez AL; Prado CM; Ureshino RP
    FASEB J; 2020 Nov; 34(11):14103-14119. PubMed ID: 32965736
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiovascular Complications Associated with COVID-19 and Potential Therapeutic~Strategies.
    Samidurai A; Das A
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32947927
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coronavirus Disease 2019 (COVID-19) set to increase burden of atherosclerotic cardiovascular disease in Kenya.
    Ogeng'o J; Karau PB; Misiani M; Cheruiyot I; Olabu B; Kariuki BN
    Pan Afr Med J; 2020; 35(Suppl 2):120. PubMed ID: 33282075
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sex-Related Factors in Cardiovascular Complications Associated to COVID-19.
    Megiorni F; Pontecorvi P; Gerini G; Anastasiadou E; Marchese C; Ceccarelli S
    Biomolecules; 2021 Dec; 12(1):. PubMed ID: 35053169
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiovascular complications of SARS-CoV-2 infection (COVID-19): a systematic review and meta-analysis.
    Zhao YH; Zhao L; Yang XC; Wang P
    Rev Cardiovasc Med; 2021 Mar; 22(1):159-165. PubMed ID: 33792257
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The contrasting role of nasopharyngeal angiotensin converting enzyme 2 (ACE2) transcription in SARS-CoV-2 infection: A cross-sectional study of people tested for COVID-19 in British Columbia, Canada.
    Nikiforuk AM; Kuchinski KS; Twa DDW; Lukac CD; Sbihi H; Basham CA; Steidl C; Prystajecky NA; Jassem AN; Krajden M; Patrick DM; Sekirov I
    EBioMedicine; 2021 Apr; 66():103316. PubMed ID: 33819740
    [TBL] [Abstract][Full Text] [Related]  

  • 34. COVID-19 and Cardiovascular Diseases: From Cellular Mechanisms to Clinical Manifestations.
    Shu H; Wen Z; Li N; Zhang Z; Ceesay BM; Peng Y; Zhou N; Wang DW
    Aging Dis; 2023 Dec; 14(6):2071-2088. PubMed ID: 37199573
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathological Interplay and Clinical Complications between COVID-19 and Cardiovascular Diseases: An Overview in 2023.
    Zhou S; Zhang A; Liao H; Liu Z; Yang F
    Cardiology; 2024; 149(1):60-70. PubMed ID: 37586358
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coronavirus disease 2019 and cardiovascular complications: focused clinical review.
    Saeed S; Tadic M; Larsen TH; Grassi G; Mancia G
    J Hypertens; 2021 Jul; 39(7):1282-1292. PubMed ID: 33687179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of COVID-19 infection on the cardiovascular system: An evidence-based analysis of risk factors and outcomes.
    Kaye AD; Spence AL; Mayerle M; Sardana N; Clay CM; Eng MR; Luedi MM; Carroll Turpin MA; Urman RD; Cornett EM
    Best Pract Res Clin Anaesthesiol; 2021 Oct; 35(3):437-448. PubMed ID: 34511231
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of cardiovascular disease and acute cardiac injury on fatal COVID-19: a meta-analysis.
    Long J; Luo Y; Wei Y; Xie C; Yuan J
    Am J Emerg Med; 2021 Oct; 48():128-139. PubMed ID: 33895644
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Depression pandemic and cardiovascular risk in the COVID-19 era and long COVID syndrome: Gender makes a difference.
    Bucciarelli V; Nasi M; Bianco F; Seferovic J; Ivkovic V; Gallina S; Mattioli AV
    Trends Cardiovasc Med; 2022 Jan; 32(1):12-17. PubMed ID: 34619336
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiac arrhythmias associated with COVID-19 infection: state of the art review.
    Mohammad M; Emin M; Bhutta A; Gul EH; Voorhees E; Afzal MR
    Expert Rev Cardiovasc Ther; 2021 Oct; 19(10):881-889. PubMed ID: 34702128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.